Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. Financials
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
Delayed Xetra  -  11:36 2022-09-30 am EDT
1.465 EUR   +2.45%
09/06Biofrontera Obtains Notice of Allowance for US Patent Related to Nanoemulsion Technology
MT
08/25Biofrontera AG Appoints Prof. Dr. Karin Lergenmüller to the Supervisory Board
CI
08/19Biofrontera AG Announces Appointment of Pilar de la Huerta Martinez as New Chief Financial Officer
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 20614683,983,1--
Enterprise Value (EV)1 20614683,983,183,183,1
P/E ratio -28,8x-12,7x2,18x-2,44x-29,3x
Yield ------
Capitalization / Revenue 6,60x4,80x2,92x3,17x2,72x2,06x
EV / Revenue 6,60x4,80x2,92x3,17x2,72x2,06x
EV / EBITDA ---2,62x51,9x92,3x19,3x
Price to Book ------
Nbr of stocks (in thousands) 44 84947 74856 71756 717--
Reference price (EUR) 4,603,051,481,471,471,47
Announcement Date 04/20/202004/12/202104/30/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 31,330,328,826,230,540,4
EBITDA1 ---32,11,600,904,30
Operating profit (EBIT)1 -23,4-7,61-35,30,900,203,60
Operating Margin -74,8%-25,1%-123%3,44%0,66%8,91%
Pre-Tax Profit (EBT)1 -4,78-12,735,7-38,10,203,60
Net income1 -7,36-13,038,3-38,10,203,10
Net margin -23,5%-42,9%133%-145%0,66%7,67%
EPS2 -0,16-0,240,68-0,60-0,05
Dividend per Share ------
Announcement Date 04/20/202004/12/202104/30/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 5,487,625,3810,36,578,51
EBITDA ------
Operating profit (EBIT) -4,09-3,49-4,99-22,81,15-
Operating Margin -74,6%-45,9%-92,8%-221%17,5%-
Pre-Tax Profit (EBT)1 -4,88-3,96-5,3850,3-28,1-7,96
Net income1 -4,88-4,00-5,8053,0-28,1-8,65
Net margin -89,0%-52,5%-108%514%-428%-102%
EPS -0,09-0,07-0,10---
Dividend per Share ------
Announcement Date 05/11/202108/19/202111/17/202104/30/202205/17/202208/19/2022
1 EUR in Million
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -37,4-6,2929,8-8,90-4,001,20
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 -0,770,630,700,600,60
Capex / Sales -2,55%2,19%2,67%1,97%1,49%
Announcement Date 04/20/202004/12/202104/30/2022---
1 EUR in Million
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 83 090 969
Capitalization (USD) 81 477 710
Net sales (EUR) 28 787 000
Net sales (USD) 28 228 084
Number of employees 98
Sales / Employee (EUR) 293 745
Sales / Employee (USD) 288 042
Free-Float 43,4%
Free-Float capitalization (EUR) 36 081 296
Free-Float capitalization (USD) 35 380 757
Avg. Exchange 20 sessions (EUR) 50 987
Avg. Exchange 20 sessions (USD) 49 997
Average Daily Capital Traded 0,06%
EPS & Dividend
Year-on-year evolution of the PER